.png){kind=icon}
返回
Estimating Error Rates in Bioactivity Databases
.png){kind=icon}
PRE
AI
DOI：10.1021/ci400099q.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Bioactivity databases are routinely used in drug discovery to look-up and, using prediction tools, to predict potential targets for small molecules. These databases are typically manually curated from patents and scientific articles. Apart from errors in the source document, the human factor can cause errors during the extraction process. These errors can lead to wrong decisions in the early drug discovery 0 process. In the current work, we have compared bioactivity data from three large databases (ChEMBL, Liceptor, and WOMBAT) who have curated data from the same source documents. As a result, we are able to report error rate estimates for individual activity parameters and individual bioactivity databases. Small molecule structures have the greatest estimated error rate followed by target, activity value, and activity type. This order is also reflected in supplier-specific error rate estimates. The results are also useful in identifying data points for recuration. We hope the results will lead to a more widespread awareness among scientists on the frequencies and types of errors in bioactivity data.
Keyword:
CURATION
QUALITY
期刊
IF:
5.3
论文数:
9.1K
被引数:
4.0W
机构
引用论文
A quality alert and call for improved curation of public chemistry databases.png)
DRUG DISCOVERY TODAY
DRUG DISCOVERY TODAYIF7.5
PREAI
分享收藏Towards a gold standard: regarding quality in public domain chemistry databases and approaches to improving the situationDRUG DISCOVERY TODAY
DRUG DISCOVERY TODAYIF7.5
PREAI
分享收藏ChEMBL: a large-scale bioactivity database for drug discoveryChEMBL: 用于药物发现的大规模生物活性数据库NUCLEIC ACIDS RESEARCH
OAAI
NUCLEIC ACIDS RESEARCHIF13.1
OAAI分享收藏
查看更多内容